ING Group’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-29,050
Closed -$16K – 652
2016
Q3
$16K Hold
29,050
– – ﹤0.01% 565
2016
Q2
$17K Buy
+29,050
New +$31K ﹤0.01% 516

Other funds holding NWBO

ING Group's NWBO Position: Q4 2016 in Review

ING Group sold out of Northwest Biotherapeutics (NWBO) in Q4 2016, closing a stake of 29,050 shares — an estimated $16K sold.

ING Group first reported a position in NWBO in Q2 2016 and held it in 2 quarters. The position peaked at $17K in Q2 2016. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • ING Group reported no remaining Northwest Biotherapeutics position as of Q4 2016 after selling out during the quarter.
  • ING Group sold 29,050 Northwest Biotherapeutics shares in Q4 2016, an estimated $16K.
  • ING Group first reported a position in Northwest Biotherapeutics in Q2 2016 and held it in 2 quarters.
  • ING Group's Northwest Biotherapeutics position peaked at $17K in Q2 2016.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q4 2016.

Based on ING Group's 13F filing for Q4 2016, filed 6 Feb 2017.